These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24665877)

  • 1. Possible association of FAS and FASLG polymorphisms with the risk of idiopathic azoospermia in southeast Turkey.
    Balkan M; Atar M; Erdal ME; Rustemoğlu A; Yildiz I; Gunesacar R; Hatipoğlu NK; Bodakçi MN; Ay OI; Çevik K
    Genet Test Mol Biomarkers; 2014 Jun; 18(6):383-8. PubMed ID: 24665877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FAS and FASLG polymorphisms and susceptibility to idiopathic azoospermia or severe oligozoospermia.
    Wang W; Lu N; Xia Y; Gu A; Wu B; Liang J; Zhang W; Wang Z; Su J; Wang X
    Reprod Biomed Online; 2009 Jan; 18(1):141-7. PubMed ID: 19146781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of FAS-670A/G and FASL-844C/T polymorphisms with idiopathic azoospermia in Western Iran.
    Asgari R; Mansouri K; Bakhtiari M; Bidmeshkipour A; Yari K; Shaveisi-Zadeh F; Vaisi-Raygani A
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():55-59. PubMed ID: 28942044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of death pathway genes FAS and FASL polymorphisms in chronic HBV infection.
    Zamani AG; Barlas IO; Durakbasi-Dursun G; Ural O; Erdal E; Yildirim MS
    Int J Immunogenet; 2013 Dec; 40(6):482-7. PubMed ID: 23560484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of alopecia areata.
    Kalkan G; Ateş O; Karakuş N; Sezer S
    Arch Dermatol Res; 2013 Dec; 305(10):909-15. PubMed ID: 23591741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas and Fas ligand gene polymorphisms in Turkish patients with Familial Mediterranean Fever.
    Ozel EG; Duran GG; Celik MM; Duran N; Gunesacar R
    Gene; 2017 Aug; 623():29-32. PubMed ID: 28442396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck.
    Zhang Z; Wang LE; Sturgis EM; El-Naggar AK; Hong WK; Amos CI; Spitz MR; Wei Q
    Clin Cancer Res; 2006 Sep; 12(18):5596-602. PubMed ID: 17000697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional polymorphisms of the FAS/FASLG genes are associated with risk of alopecia areata in a Chinese population: a case-control analysis.
    Fan X; Shangguan L; Li M; Li CY; Liu B
    Br J Dermatol; 2010 Aug; 163(2):340-4. PubMed ID: 20394629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between FAS/FASL gene polymorphisms and susceptibility of coal worker's pneumoconiosis].
    Ni CH; Song ZF; Jia XM; Li AP; Li CP; Li SK; Li YM; Wang ZL; Zhou Y; Wang SY; Zhang ZD; Zhou JW
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2007 Sep; 25(9):532-6. PubMed ID: 17997887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-Nucleotide Polymorphisms of FAS and FASL Genes and Risk of Idiopathic Aplastic Anemia.
    Rehman S; Saba N; Naz M; Ahmed P; Munir S; Sajjad S; Tabassum S; Naseem L
    Immunol Invest; 2018 Jul; 47(5):484-491. PubMed ID: 29611722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association of FASL-844 polymorphism with the risk of idiopathic azoospermia and severe oligozoospermia].
    Wang W; Lu NX; Xia YA; Wang XR; Zhang W; Song NH; Wei M; Su JT
    Zhonghua Nan Ke Xue; 2007 Apr; 13(4):302-5. PubMed ID: 17491259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma.
    Li C; Larson D; Zhang Z; Liu Z; Strom SS; Gershenwald JE; Prieto VG; Lee JE; Ross MI; Mansfield PF; Cormier JN; Duvic M; Grimm EA; Wei Q
    Pharmacogenet Genomics; 2006 Apr; 16(4):253-63. PubMed ID: 16538172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy.
    Zhang F; Sturgis EM; Sun Y; Zhang Y; Wei Q; Zhang C; Zheng H; Li G
    Int J Cancer; 2015 Nov; 137(10):2454-61. PubMed ID: 25976983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
    Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
    Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overlapping and Distinct
    Tabatabaei-Panah PS; Moravvej H; Arian S; Fereidonpour I; Behravesh N; Atoon A; Ludwig RJ; Akbarzadeh R
    Immunol Invest; 2020 Feb; 49(1-2):204-214. PubMed ID: 31741398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FAS and FAS ligand gene polymorphisms in Egyptian females with preeclampsia.
    Nasr AS; Abdel Aal AA; Soliman A; Setohy KA; Shehata MF
    J Reprod Immunol; 2014 Oct; 104-105():63-7. PubMed ID: 24951049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of prostate cancer in a Chinese population.
    Shao P; Ding Q; Qin C; Wang M; Tang J; Zhu J; Chen J; Cao Q; Li J; Xu B; Zhang Z; Zhang W; Yin C
    Prostate; 2011 Jul; 71(10):1122-30. PubMed ID: 21557277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis.
    Li C; Wu W; Liu J; Qian L; Li A; Yang K; Wei Q; Zhou J; Zhang Z
    Pharmacogenet Genomics; 2006 Apr; 16(4):245-51. PubMed ID: 16538171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms of IL-1A, IL-1B, IL-1RN, NFKB1, FAS, and FASL, and risk of silicosis in a Chinese occupational population.
    Wu F; Xia Z; Qu Y; Tang Y; Cao D; Sun P; Christiani DC
    Am J Ind Med; 2008 Nov; 51(11):843-51. PubMed ID: 18666137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility to oral cancers with CD95 and CD95L promoter SNPs may vary with the site and gender.
    Daripally S; Nallapalle SR; Katta S; Prasad VV
    Tumour Biol; 2015 Sep; 36(10):7817-30. PubMed ID: 25944167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.